Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation

Toxicology and Applied Pharmacology

Volumn 272, Issue 2, 2013, Pages 313-324

  Chen, Jing Hsien ^a,b   Tsai, Chia Wen ^c   Wang, Chi Ping ^b   Lin, Hui Hsuan ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Cholesterol removal; Foam cells; Gossypetin; Oxidation; Oxidized low density lipoprotein

Indexed keywords

1,1 DIPHENYL 2 PICRYLHYDRAZYL; ABC TRANSPORTER A1; APOLIPOPROTEIN B; CD36 ANTIGEN; CUPROUS ION; GOSSYPETIN; HYPOCHOLESTEROLEMIC AGENT; LIVER X RECEPTOR ALPHA; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; ELECTROPHORETIC MOBILITY; FOAM CELL; GENETIC TRANSFECTION; HUMAN; INTRACELLULAR SIGNALING; INTRACELLULAR SPACE; LIPID OXIDATION; LIPID STORAGE; MACROPHAGE; NONHUMAN; NORMAL HUMAN;

1,1-DIPHENYL-2-PICRYLHYDRAZYL; 3-(4,5-DIMETHYLTHIAZOL-ZYL)-2,5-DIPHENYLTETRAZOLIUM BROMIDE; ABCA1; ACETYLATED LDL; ACLDL; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTER A1; CHOLESTEROL REMOVAL; CLASS A SCAVENGE RECEPTORS; DPPH; ECL; ENHANCED CHEMILUMINESCENCE; FOAM CELLS; GOSSYPETIN; LDL; LIVER-X RECEPTOR Α; LOW-DENSITY LIPOPROTEIN; LXRΑ; MTT; OX-LDL; OXIDATION; OXIDIZED LDL; OXIDIZED LOW-DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PPARS; RELATIVE ELECTROPHORETIC MOBILITY; REM; SDS-PAGE; SODIUM DODECYL SULFATE POLYACRYLAMIDE GEL ELECTROPHORESIS; SR-AS; TBARS; TBS; THIOBARBITURIC ACID REACTIVE SUBSTANCES; TRIS-BUFFERED SALINE;

ANIMALS; ATHEROSCLEROSIS; BIPHENYL COMPOUNDS; CELL CULTURE TECHNIQUES; CELL LINE; CELL SURVIVAL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FLAVONOIDS; FOAM CELLS; FREE RADICAL SCAVENGERS; HUMANS; LIPID PEROXIDATION; LIPOPROTEINS, LDL; MICE; PICRATES; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84883784008     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2013.06.027     Document Type: Article

References (44)

1. Afanas'ev I.B., Dorozhko A.I., Brodskii A.V., Kostyuk V.A., Potapovitch A.I. Chelating and free radical scavenging mechanisms of inhibitory actions of rutin and quercetin in lipid peroxidation. Biochem. Pharmacol. 1989, 38:1763-1769.
2. Alcaraz M.J., Hoult J.R. Effects of hypolaetin-8-glucoside and related flavonoids on soybean lipoxygenase and snake venom phospholipase A2. Arch. Int. Pharmacodyn. Ther. 1985, 278:4-12.
3. Bors W., Saran M. Radical scavenging by flavonoid antioxidants. Free Radic. Res. Commun. 1987, 2:289-294.
4. Chang Y.C., Huang K.X., Huang A.C., Ho Y.C., Wang C.J. Hibiscus anthocyanins-rich extract inhibited LDL oxidation and oxLDL-mediated macrophages apoptosis. Food Chem. Toxicol. 2006, 44:1015-1023.
5. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Mol. Cell 2001, 7:161-171.
6. Chinetti G., Lestavel S., Bocher V., Remaley A.T., Neve B., Torra I.P., Teissier E., Minnich A., Jaye M., Duverger N., Brewer H.B., Fruchart J.C., Clavey V., Staels B. PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat. Med. 2001, 7:53-58.
7. Choi J.S., Bae J.Y., Kim D.S., Li J., Kim J.L., Lee Y.J., Kang Y.H. Dietary compound quercitrin dampens VEGF induction and PPARgamma activation in oxidized LDL-exposed murine macrophages: association with scavenger receptor CD36. J. Agric. Food Chem. 2010, 58:1333-1341.
8. Danni O., Sawyer B.C., Slater T.F. Effects of (+)-catechin in vitro and in vivo on disturbances produced in rat liver endoplasmic reticulum by carbon tetrachloride. Biochem. Soc. Trans. 1977, 5:1029-1032.
9. de Whalley C.V., Rankin S.M., Hoult J.R., Jessup W., Leake D.S. Flavonoids inhibit the oxidative modification of low density lipoproteins by macrophages. Biochem. Pharmacol. 1990, 39:1743-1750.
10. Feng J., Han J., Pearce S.F., Silverstein R.L., Gotto A.M., Hajjar D.P., Nicholson A.C. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J. Lipid Res. 2000, 41:688-696.
11. Francis A.R., Shetty T.K., Bhattacharya R.K. Modulating effect of plant flavonoids on the mutagenicity of N-methyl-N'-nitro-N-nitrosoguanidine. Carcinogenesis 1989, 10:1953-1955.
12. Gábor M. Anti-inflammatory and anti-allergic properties of flavonoids. Prog. Clin. Biol. Res. 1986, 213:471-480.
13. Gaziano J.M., Manson J., Buring J.E., Hennekens C.H. Dietary antioxidants and cardiovascular disease. Ann. N. Y. Acad. Sci. 1992, 669:249-259.
14. Geraets L., Moonen H.J., Brauers K., Wouters E.F., Bast A., Hageman G.J. Dietary flavones and flavonoles are inhibitors of poly(ADP-ribose)polymerase-1 in pulmonary epithelial cells. J. Nutr. 2007, 137:2190-2195.
15. Han J., Zhou X., Yokoyama T., Hajjar D.P., Gotto A.M., Nicholson A.C. Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36. Circulation 2004, 109:790-796.
16. Hirunpanich V., Utaipat A., Morales N.P., Bunyapraphatsara N., Sato H., Herunsalee A., Suthisisang C. Antioxidant effects of aqueous extracts from dried calyx of Hibiscus sabdariffa Linn. (Roselle) in vitro using rat low-density lipoprotein (LDL). Biol. Pharm. Bull. 2005, 28:481-484.
17. Inoue M., Itoh H., Tanaka T., Chun T.H., Doi K., Fukunaga Y., Sawada N., Yamshita J., Masatsugu K., Saito T., Sakaguchi S., Sone M., Yamahara Ki, Yurugi T., Nakao K. Oxidized LDL regulates vascular endothelial growth factor expression in human macrophages and endothelial cells through activation of peroxisome proliferator-activated receptor-gamma. Arterioscler. Thromb. Vasc. Biol. 2001, 21:560-566.
18. Jeong H.J., Ryu Y.B., Park S.J., Kim J.H., Kwon H.J., Kim J.H., Park K.H., Rho M.C., Lee W.S. Neuraminidase inhibitory activities of flavonols isolated from Rhodiola rosea roots and their in vitro anti-influenza viral activities. Bioorg. Med. Chem. 2009, 17:6816-6823.
19. Larrede S., Quinn C.M., Jessup W., Frisdal E., Olivier M., Hsieh V., Kim M.J., Van Eck M., Couvert P., Carrie A., Giral P., Chapman M.J., Guerin M., Le Goff W. Stimulation of cholesterol efflux by LXR agonists in cholesterol-loaded human macrophages is ABCA1-dependent but ABCG1-independent. Arterioscler. Thromb. Vasc. Biol. 2009, 29:1930-1936.
20. Lee M.J., Chou F.P., Tseng T.H., Hsieh M.H., Lin M.C., Wang C.J. Hibiscus protocatechuic acid or esculetin can inhibit oxidative LDL induced by either copper ion or nitric oxide donor. J. Agric. Food Chem. 2002, 50:2130-2136.
21. Lian T.W., Wang L., Lo Y.H., Huang I.J., Wu M.J. Fisetin, morin and myricetin attenuate CD36 expression and oxLDL uptake in U937-derived macrophages. Biochim. Biophys. Acta 2008, 1781:601-609.
22. Lin H.H., Chen J.H., Kuo W.H., Wang C.J. Chemopreventive properties of Hibiscus sabdariffa L. on human gastric carcinoma cells through apoptosis induction and JNK/p38 MAPK signaling activation. Chem. Biol. Interact. 2007, 165:59-75.
23. Lin H.H., Chen J.H., Wang C.J. Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne. Curr. Med. Chem. 2011, 18:1245-1254.
24. Lin H.H., Tsai C.W., Chou F.P., Wang C.J., Hsuan S.W., Wang C.K., Chen J.H. Andrographolide down-regulates hypoxia-inducible factor-1α in human non-small cell lung cancer A549 cells. Toxicol. Appl. Pharmacol. 2011, 250:336-345.
25. Miceli N., Trovato A., Dugo P., Cacciola F., Donato P., Marino A., Bellinghieri V., La Barbera T.M., Güvenç A., Taviano M.F. Comparative analysis of flavonoid profile, antioxidant and antimicrobial activity of the berries of Juniperus communis L. var. communis and Juniperus communis L. var. saxatilis Pall. from Turkey. J. Agric. Food Chem. 2009, 57:6570-6577.
26. Middleton E.J., Kandaswami C. The impact of plant flavonoids on mammalian biology: implications for immunity, inflammation and cancer. The Flavonoids: Advances in Research Since 1986 1993, 619-652. Chapman & Hall, London. J.B. Harborne (Ed.).
27. Min K.J., Um H.J., Cho K.H., Kwon T.K. Curcumin inhibits oxLDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem. Toxicol. 2013, 58C:77-85.
28. Moroney M.A., Alcaraz M.J., Forder R.A., Carey F., Hoult J.R. Selectivity of neutrophil 5-lipoxygenase and cyclo-oxygenase inhibition by an anti-inflammatory flavonoid glycoside and related aglycone flavonoids. J. Pharm. Pharmacol. 1988, 40:787-792.
29. Nabzdyk C.S., Lancero H., Nguyen K.P., Salek S., Conte M.S. RNA interference-mediated survivin gene knockdown induces growth arrest and reduced migration of vascular smooth muscle cells. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1841-H1849.
30. Nicholson S.K., Tucker G.A., Brameld J.M. Effects of dietary polyphenols on gene expression in human vascular endothelial cells. Proc. Nutr. Soc. 2008, 67:42-47.
31. Nijveldt R.J., van Nood E., van Hoorn D.E., Boelens P.G., van Norren K., van Leeuwen P.A. Flavonoids: a review of probable mechanisms of action and potential applications. Am. J. Clin. Nutr. 2001, 74:418-425.
32. Pierpoint W.S. Flavonoids in the human diet. Prog. Clin. Biol. Res. 1986, 213:125-140.
33. Rice-Evans C.A., Miller N.J., Paganga G. Structure-antioxidant activity relationships of flavonoids and phenolic acids. Free Radic. Biol. Med. 1996, 20:933-956.
34. Ross R. Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
35. Sato O., Kuriki C., Fukui Y., Motojima K. Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor alpha and gamma ligands. J. Biol. Chem. 2002, 277:15703-15711.
36. Sevov M., Elfineh L., Cavelier L.B. Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochem. Biophys. Res. Commun. 2006, 348:1047-1054.
37. Slater T.F., Cheeseman K.H., Davies M.J., Hayashi M., Sharma O.P., Nigam S., Benedetto C. Free radical scavenging properties of modulators of eicosanoid metabolism. Adv. Prostaglandin Thromboxane Leukot. Res. 1987, 17B:1098-1102.
38. Steinberg D., Parthasarathy S., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N. Engl. J. Med. 1989, 320:915-924.
39. Tontonoz P., Nagy L., Alvarez J.G., Thomazy V.A., Evans R.M. PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell 1998, 93:241-252.
40. Wang K.J., Zhang Y.J., Yang C.R. Antioxidant phenolic constituents from Fagopyrum dibotrys. J. Ethnopharmacol. 2005, 99:259-264.
41. Xu S., Huang Y., Xie Y., Lan T., Le K., Chen J., Chen S., Gao S., Xu X., Shen X., Huang H., Liu P. Evaluation of foam cell formation in cultured macrophages: an improved method with Oil Red O staining and DiI-oxLDL uptake. Cytotechnology 2010, 62:473-481.
42. Yang M.Y., Huang C.N., Chan K.C., Yang Y.S., Peng C.H., Wang C.J. Mulberry leaf polyphenols possess antiatherogenesis effect via inhibiting LDL oxidation and foam cell formation. J. Agric. Food Chem. 2011, 59:1985-1995.
43. Yoshikawa M., Shimada H., Shimoda H., Matsuda H., Yamahara J., Murakami N. Rhodiocyanosides A and B, new antiallergic cyanoglycosides from Chinese natural medicine "si lie hong jing tian", the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. Chem. Pharm. Bull. (Tokyo) 1995, 43:1245-1247.
44. Yoshikawa M., Shimada H., Shimoda H., Murakami N., Yamahara J., Matsuda H. Bioactive constituents of Chinese natural medicines. II. Rhodiolae radix. (1). Chemical structures and antiallergic activity of rhodiocyanosides A and B from the underground part of Rhodiola quadrifida (Pall.) Fisch. et Mey. (Crassulaceae). Chem. Pharm. Bull. (Tokyo) 1996, 44:2086-2091.